Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses
Pharmaceutics · 13.02.2023 · 15 (2) · 625
DOI: 10.3390/pharmaceutics15020625 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 13.02.2023. Verfasst von Letizia Pelusi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Oral and Biotechnological Sciences, Center for Advanced Studies and Technology-CAST, StemTeCh Group, University G. D'Annunzio …. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PON-MISE Sustainable Growth Funding-DD27 September 2018, PON R&I “Ricerca e Innovazione” 2014–2020.
Abstract (Originalsprache)
Nowadays, ocular drug delivery still remains a challenge, since the conventional dosage forms used for anterior and posterior ocular disease treatments, such as topical, systemic, and intraocular administration methods, present important limitations mainly related to the anatomical complexity of the eye. In particular, the blood–ocular barrier along with the corneal barrier, ocular surface, and lacrimal fluid secretion reduce the availability of the administered active compounds and their efficacy. These limitations have increased the need to develop safe and effective ocular delivery systems able to sustain the drug release in the interested ocular segment over time. In the last few years, thanks to the innovations in the materials and technologies employed, different ocular drug delivery systems have been developed. Therefore, this review aims to summarize the synthetic and natural drug-loaded ocular inserts, contacts, and intraocular lenses that have been recently developed, emphasizing the characteristics that make them promising for future ocular clinical applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical, Oral and Biotechnological Sciences, Center for Advanced Studies and Technology-CAST, StemTeCh Group, University G. D'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.
- Department of Medicine and Aging Science, Ophthalmology Clinic, University G. D'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.
- Dompé Farmaceutici SpA, Via Campo di Pile, 67100 L'Aquila, Italy.
ORCID-Profile: Marcello Allegretti, Assunta Pandolfi
Förderung
- PON-MISE Sustainable Growth Funding-DD27 September 2018
- PON R&I “Ricerca e Innovazione” 2014–2020
Zitieren
APA
Pelusi, L., Mandatori, D., Mastropasqua, L., Agnifili, L., Allegretti, M., Nubile, M., & Pandolfi, A. (2023). Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses. Pharmaceutics, 15(2), 625. https://doi.org/10.3390/pharmaceutics15020625
Vancouver
Pelusi L, Mandatori D, Mastropasqua L, Agnifili L, Allegretti M, Nubile M, et al. Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses. Pharmaceutics. 2023;15(2):625. doi:10.3390/pharmaceutics15020625
BibTeX
@article{Pelusi2023,
author = {Pelusi, Letizia and Mandatori, Domitilla and Mastropasqua, Leonardo and Agnifili, Luca and Allegretti, Marcello and Nubile, Mario and Pandolfi, Assunta},
title = {Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {2},
pages = {625},
doi = {10.3390/pharmaceutics15020625}
}
EUVIMED